| Indicator(s) |
Organism(s) |
| Gm+, alpha-hemolytic, lancet-shaped, quellung positive |
Strep pneumoniae |
| Stys |
Staph aureus |
| Pyoarthritis from disseminated infections |
Staph aureus |
| UTI in elderly |
Staph epidermidis |
| UTI in adolescent girls |
Staph saprophyticus |
| Neonatal sepsis |
Group B Strep agalactiae |
| PID |
Neisseria gonorrhea |
| macular rash and petechial hemorrhages |
fulminant meningococcemia - Neisseria meningitidis |
| Organisms present in blood, nasopharyngeal swab, very few in CSF |
Neisseria meningitidis |
| Carrion’s disease |
Bartonella Bacilliformis |
| oroya fever |
Bartonella Bacilliformis |
| sand flies |
Bartonella Bacilliformis |
| Cat scratch fever |
Bartonella henselae |
| Trench fever |
Bortonella quiltana |
| Passive immunity by mother/Natural immunity by 8 years old |
Haemophilus influenzae |
| Soft, painful chancres in genital region |
Haemophilus ducreyi |
| Soft, painless chancres in genital region |
Treponema pallidum (syphilis) |
| Soft chancres in genital region |
Haemophilus ducreyi OR Treponema pallidum (syphilis) |
| Cause meningitis (NOT late onset neonatal sepsis) |
haemophilis infulenzae, neisseria menigitidis, strep pneumoniae, moraxilla |
| Late onset neonatal sepsis meninigitis |
strep B (agalactiae) |
| Causes pneumonia |
Strep pneumoniae, haemophilis influenzae, staph aureus, peptostreptococci |
| Quellung positive |
haemophilis influenzae, strep pneumoniae, neisseria menigitidis |
| Condition from the release of endotoxin by bacteria killed by an antibiotic |
Jarisch-Herxheimer reaction |
| Treatment for Bordetella pertussis |
Erythromycin to kill B.pertussis, then continued antibiotics to prevent pneumonia |
| catalase +, facultative anaerobes, hyaluronidase, pyrogenic |
STAPH |
| teichoic acid |
STAPH |
| protein A |
Antiphagocytic - STAPH |
| mucus membrane pathogens |
Neisseria, Haemophilus, Moraxella |
| Most common staph |
Staph aureus |
| Golden yellow pigment on solid media, white to orange colonies |
Staph aureus |
| Mannitol + |
Staph aureus |
| Coagulase + |
Staph aureus |
| Ribitol teichoic acid |
Staph aureus |
| Gm+, produces enterotoxin |
Staph aureus |
| Abscess formation |
Staph aureus |
| Encrusted pustules on superficial layers of skin |
Impetigo - Staph aureus/Strep A (pyogenes) |
| pyoarthritis |
Disseminated infection of staph aureus or PID in Neisseria gonorrhea |
| acute bacterial endocarditis |
staph aureus |
| subacute bacterial endocarditis |
staph epidermidis |
| most common endocarditis |
strep viridans |
| all bacterial endocarditis causes |
Staph aureus, staph epidermidis, strep viridans, strep A (pyogenes), strep D (fecalis), moraxella (branhamella catarrhalis) |
| sandpaper texture, streaking of skin on joint lines, can start to peel |
Scalded skin syndrome - staph aureus |
| High fever, vomiting, diarrhea, peripheral circulatory collapse, tampons |
TSS - staph aureus |
| Acute vomiting, mild cramps, no fever, 2-6 hours after ingestion |
Food poisoning - staph aureus |
| White colonies |
Staph epidermidis |
| Glycerol teichoic acid |
Staph epidermidis |
| Glycerol and or rubitol teichoic acid |
Staph saprophyticus |
| Gm+ chained cocci, non-motile, catalase –, facultative anerobes |
STREP |
| Hyaluronic acid capsule |
STREP |
| Protein F |
fibronectin binding - STREP |
| Lactic acid fermentors |
STREP |
| Group A |
Strep pyogenes |
| M, T, and R antigens |
Strep A (pyogenes) |
| beta-hemolytic, bactracin sensitive |
Strep A (pyogenes) |
| M-protein |
Antiphagocytosis - Strep A (pyogenes) |
| Strep A hemolysins |
Streptolysin S (O2 STABLE) and O (O2 SENSITIVE) |
| Most common pharyngitis |
Strep A (pyogenes) |
| Scarlet Fever |
Strep A (pyogenes) |
| pyoderma (impetigo) |
Staph aureus, Strep A (pyogenes) |
| cellulitis |
Strep A (pyogenes) |
| Rheumatic fever |
Strep A (pyogenes) |
| Acute glomerulonephritis |
Strep A (pyogenes) |
| Strep group B |
Strep agalactiae |
| Beta-hemolytic, bactracin resistant, normal oral/vaginal flora |
Strep B (agalactiae) |
| Sialic acid capsule |
Strep B (agalactiae) |
| 5 serotypes |
Strep B (agalactiae) |
| serotype of late-onset neonatal sepsis |
3 |
| alpha-hemolytic, bactracin resistant |
strep D non-enterococci |
| beta-hemolytic, bactracin resistant, inhibited (not killed) by penicillin |
strep D enterococci (fecalis) |
| Strep D enterococci |
Strep fecalis |
| NON Strep Group D Enterococci |
E. faecalis, E. faecium |
| PYR + |
NON Strep Group D Enterococci (E. faecalis, E. faecium) |
| Strep D diseases |
endocarditis, UTI, septicemia |
| Strep D treatment |
Need an antibiotic sensitivity test |
| Anaerobic, Gm+ cocci |
Peptostreptococci |
| Normal in GI, Gu, and especially in periodontal |
Peptostreptococci |
| Possible diseases of Peptostreptococci |
abscess, pneumonia, Gu tract infections |
| alpha-hemolytic, found in the oral cavity and heart |
strep viridans |
| strep viridans diseases |
dental caries, endocarditis |
| strep viridans treatment |
penicillin |
| alpha hemolytic, sensitive to bile and quinine |
strep pneumoniae |
| strep pneumoniae diseases |
pneumonia (usually secondary infection), meningitis, otitis media/septicemia in infants > 2 months old |
| strep pneumoniae treatment |
usually penicillin, or other antibiotic |
| strep pneumoniae vaccine |
capsular polysaccharide, only in adults |
| Virulent neisseria |
Types 1 and 2, which have capsules - gonorrhea and meningitidis |
| neisseria motility |
twitching pili. NO FLAGELLA |
| Glucose fermentor only |
Neisseria gonorrhea |
| STD, diplococci, pyogen |
Neisseria gonorrhea |
| IgAse |
Neisseria gonorrhea, Haemophilus influenzae |
| Urethritis |
Moraxella, Neisseria gonorrhea |
| Diseases of Neisseria gonorrhea |
urithritis, rectal infection, pharyngitis, ophtalmia neonatorum |
| Culture on thayer-martin chocolate plate in candle (CO2) jar |
Neisseria gonorrhea |
| Neisseria gonorrhea treatment |
penicillin G |
| penicillinase+ Neisseria gonorrhea treatment |
spectinomycin |
| Glucose and maltose fermentation only |
Neisseria meningitidis |
| quellung+, natural reservoir in nasopharynx |
Neisseria meningitidis |
| fever, vomiting, headache, stiff neck |
meningitis, early stages |
| Waterhouse-friderichsen syndrome |
Neisseria meningitidis |
| Neisseria meningitidis treatment |
High dose of IV penicillin |
| Neisseria meningitidis vaccine |
Capsular polysaccharide - infants or military settings |
| Branhamella catarrhalis |
Moraxella |
| - Gm -, diplococcobacilli, normal flora |
Moraxella (Branhamella catarrhalis) |
| Severe moraxella diseases |
endocarditis or meningitis (both rare) |
| moraxella diseases in immunocomprimised patients |
otitis media, maxillary sinusitis, pulmonary disease, urethritis (indistingushable from gonorrhea) |
| Non-motile coccobacilli w/capsule, obligate aerobe, oxidase -, natural flora |
Acinetobacter |
| Gm-, coccobacillus, no capsule, flagella, hemangioma |
Bartonella Bacilliformis |
| Pyogenic, facultative anaerobe, blood components requred |
HAEMOPHILUS |
| chocolate agar required due to non-hemolytic property |
Haemophilus infulenzae |
| Cells are pleomorphic (vary between small coccobacilli to long, slender filaments) |
Haemophilus influenzae |
| Acute bacterial meningits in 3 to 6 year-olds |
Haemophilus influenzae |
| Large number of organisms in CSF |
Haemophilus influenzae |
| Start with upper resperatory tract infection, but may lead to meningitis or epiglottitis |
Haemophilus influenzae |
| Antiphagocytic and immunosuppressive capsule with 6 serotypes |
Haemophilus influenzae |
| Haemophilus influenzae serotype that's common in children |
B |
| Haemophilus influenzae treatment |
ampicillin or chloramphenicol |
| Haemophilus influenzae vaccine |
Capsular polysaccharide conjugated to diphtheria toxoid. Used for infants |
| Bacterial conjunctivitis |
Haemophilus aegyptius |
| Haemophilus aegyptius treatment |
tetracycline ointment |
| Haemophilus ducreyi treatment |
sulfonamides and streptomycin |
| small Gm- coccobacilli with hemagglutimin pili |
attach to upper resperatory tract - Bordetella |
| Most severe Bordetella to least |
Pertussis, parapertussis, bronchiseptica |
| Unidentified toxin |
Neurotoxin - Bordetella |
| Obligate human parasite |
Bordetella pertussis |
| Whooping cough |
Bordetella pertussis |
| Mild flu-like symptoms, mild, persistent cough, MOST CONTAGIOUS |
Caterrhal Stage - Bordetella pertussis |
| Violent coughing, characteristic whoop, cyanosis, vomiting, convulsions, exhaustion |
Paraoxysmal Stage - Bordetella pertussis |
| amelioration of symptoms, cough persists for several months |
Convalescent stage - Bordetella pertussis |
| Grown on Bordet-Gengon and Regan-Lowe agar |
Bordetella pertussis |
| Bordetella vaccine |
Inactivated whole organism. Produces antibodies and cell-mediated immunity. Administered at 2 months old. Boosters at 4, 6, and 18 months, and then again when entering school. |